Signs and symptoms
Genes
Methods
Disclaimer
About us
Publications
Contact us
Patients
Users
Database
Login
Overview of included studies for PARK-SNCA:
Click here for summary of patients' characteristics
Click here for summary of genetic findings
Click here to show world map of all countries
Filter for
all included patients
index patients only
AAO < 50 (adjustable)
AAO >= 50 (adjustable)
females only
males only
homozygous only
heterozygous only
compound heterozygous only
homozygous and compound heterozygous
carrying
definitely pathogenic mutations
probably pathogenic mutations
possibly pathogenic mutations
c.(?_-1471)_(575_?)dup
c.(?_-1471)_(575_?)tri
c.464C>A
c.136G>A
c.150G>A
c.150T>G
c.152G>A
c.157G>A
c.158C>A
c.88G>C
Country
Argentina
Bolivia
China
Finland
France
Germany
Greece
Italy
Japan
Pakistan
Poland
South Korea
Spain
Sweden
United Kingdom
United States
Study
Study design
N cases
Ethnicities
Sex
(%
♂
)
Mean AAO (+/- SD)
Reported mutations
Bougea, 2017
Case report/Case series
2
C
100%
40(+/-13)
p.Ala53Thr
: het
Pasanen, 2017
Other/Mixed
1
C
0%
41
p.Ala53Glu
: n.a.
Xiong, 2016
Other/Mixed
1
A
100%
22
p.Ala53Thr
: het
Tambasco, 2016
Case report/Case series
1
C
0%
58
p.Ala53Thr
: het
Benitez, 2016
Mutational screen
1
n.a.
100%
67
c.(?_-1471)_(*575_?)dup
: het
Takamura, 2016
Case report/Case series
1
A
100%
53
c.(?_-1471)_(*575_?)dup
: het
Ricciardi, 2016
Other/Mixed
4
n.a.
75%
33(+/-10)
p.Ala53Thr
: het
Konno, 2016
Family study
1
n.a.
100%
48
c.(?_-1471)_(*575_?)dup
: het
Martikainen, 2015
Family study
2
C
0%
34(+/-12)
p.Ala53Glu
: het
Ferese, 2015
Family study
2
C
50%
n.a.
c.(?_-1471)_(*575_?)tri
: het
Kiely, 2015
Other/Mixed
2
C
n.a.
58(+/-16)
p.Gly51Asp
: n.a.
Olgiati, 2015
Family study
3
C
33%
29(+/-1)
c.(?_-1471)_(*575_?)tri
: het
Pimentel, 2015
Other/Mixed
3
H
100%
54(+/-4)
p.Glu46Lys
: het
Kara, 2014
Other/Mixed
2
C
50%
38
c.(?_-1471)_(*575_?)dup
: het
Pasanen, 2014
Other/Mixed
3
C
0%
43(+/-16)
p.Ala53Glu
: het
Tokutake, 2014
Case report/Case series
1
n.a.
0%
28
p.Gly51Asp
: het
Bozi, 2014
Mutational screen
5
C
n.a.
44(+/-12)
p.Ala53Thr
: het
Elia, 2013
Other/Mixed
4
n.a.
50%
40(+/-7)
c.(?_-1471)_(*575_?)dup
: het
Kim, 2013
Other/Mixed
1
A
100%
44
c.*464C>A
: het
Lesage, 2013
Other/Mixed
3
n.a.
33%
42(+/-16)
p.Gly51Asp
: het
Appel-Cresswell, 2013
Case report/Case series
1
n.a.
100%
60
p.His50Gln
: n.a.
Proukakis, 2013
Other/Mixed
1
C
0%
71
p.His50Gln
: het
Kiely, 2013
Family study
2
C
50%
30(+/-15)
p.Gly51Asp
: het
Kojovic, 2012
Other/Mixed
1
n.a.
0%
n.a.
c.(?_-1471)_(*575_?)dup
: hom
Garraux, 2012
Case report/Case series
1
C
0%
30
c.(?_-1471)_(*575_?)dup
: het
Meeus, 2012
Mutational screen
1
n.a.
n.a.
77
c.(?_-1471)_(*575_?)dup
: het
Sekine, 2010
Family study
1
A
100%
28
c.(?_-1471)_(*575_?)tri
: het
Shin, 2010
Other/Mixed
2
n.a.
0%
52(+/-5)
c.(?_-1471)_(*575_?)dup
: het
Sironi, 2010
Other/Mixed
1
C
0%
41
c.(?_-1471)_(*575_?)dup
: het
Nishioka, 2009
Other/Mixed
8
n.a.
63%
48(+/-11)
c.(?_-1471)_(*575_?)dup
: het
Nuytemans, 2009
Mutational screen
1
n.a.
n.a.
68
c.(?_-1471)_(*575_?)dup
: het
Ibáñez, 2009
Other/Mixed
5
n.a.
20%
44(+/-6)
c.(?_-1471)_(*575_?)dup
: het
c.(?_-1471)_(*575_?)tri
: het
Troiano, 2008
Case report/Case series
1
n.a.
0%
35
c.(?_-1471)_(*575_?)dup
: het
Uchiyama, 2008
Other/Mixed
2
A
50%
60(+/-18)
c.(?_-1471)_(*575_?)dup
: het
Ikeuchi, 2008
Family study
4
A
75%
50(+/-20)
c.(?_-1471)_(*575_?)dup
: hom
c.(?_-1471)_(*575_?)dup
: het
Markopoulou, 2008
Family study
8
C
63%
50(+/-10)
p.Ala53Thr
: het
Ahn, 2008
Other/Mixed
3
A
67%
52(+/-13)
c.(?_-1471)_(*575_?)dup
: het
Ki, 2007
Family study
1
A
100%
35
p.Ala53Thr
: het
Fuchs, 2007
Family study
2
C
100%
51(+/-28)
c.(?_-1471)_(*575_?)dup
: het
c.(?_-1471)_(*575_?)tri
: het
Nishioka, 2006
Other/Mixed
3
A
67%
44(+/-6)
c.(?_-1471)_(*575_?)dup
: het
Michell, 2005
Case report/Case series
1
C
100%
n.a.
p.Ala53Thr
: het
Chartier-Harlin, 2004
Other/Mixed
5
n.a.
40%
48(+/-10)
c.(?_-1471)_(*575_?)dup
: het
Farrer, 2004
Other/Mixed
1
C
100%
31
c.(?_-1471)_(*575_?)tri
: het
Zarranz, 2004
Family study
12
H
33%
51(+/-13)
p.Glu46Lys
: het
Singleton, 2004
Family study
2
n.a.
n.a.
48
c.(?_-1471)_(*575_?)tri
: het
Bostantjopoulou, 2001
Mutational screen
8
C
63%
40(+/-7)
p.Ala53Thr
: n.a.
Krüger, 2001
Family study
3
C
67%
62(+/-12)
p.Ala30Pro
: n.a.
Papapetropoulos, 2001
Other/Mixed
5
C
n.a.
40(+/-16)
p.Ala53Thr
: het
Spira, 2001
Other/Mixed
3
C
100%
44(+/-3)
p.Ala53Thr
: n.a.
Athanassiadou, 1999
Mutational screen
10
C
60%
48(+/-7)
p.Ala53Thr
: het
Papadimitriou, 1999
Family study
4
C
50%
43(+/-4)
p.Ala53Thr
: het
© University of Lübeck. Last updated on
Dec. 2, 2020. Version: 3.5.95
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.
MDSGene works best with JavaScript enabled. Please follow
these instructions
to activate JavaScript in your web browser.